- Home
- GOSS vs HFFG Comparison
GOSS vs HFFG Comparison
Compare GOSS & HFFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- HFFG
- Stock Information
- Founded
- GOSS 2015
- HFFG N/A
- Country
- GOSS United States
- HFFG United States
- Employees
- GOSS N/A
- HFFG N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- HFFG Food Distributors
- Sector
- GOSS Health Care
- HFFG Consumer Discretionary
- Exchange
- GOSS Nasdaq
- HFFG Nasdaq
- Market Cap
- GOSS 212.9M
- HFFG 180.3M
- IPO Year
- GOSS 2019
- HFFG N/A
- Fundamental
- Price
- GOSS $0.74
- HFFG $3.42
- Analyst Decision
- GOSS Strong Buy
- HFFG
- Analyst Count
- GOSS 5
- HFFG 0
- Target Price
- GOSS $9.20
- HFFG N/A
- AVG Volume (30 Days)
- GOSS 881.6K
- HFFG 43.4K
- Earning Date
- GOSS 11-07-2024
- HFFG 11-12-2024
- Dividend Yield
- GOSS N/A
- HFFG N/A
- EPS Growth
- GOSS N/A
- HFFG N/A
- EPS
- GOSS N/A
- HFFG N/A
- Revenue
- GOSS $105,322,000.00
- HFFG $1,177,258,000.00
- Revenue This Year
- GOSS N/A
- HFFG $4.57
- Revenue Next Year
- GOSS N/A
- HFFG $3.25
- P/E Ratio
- GOSS N/A
- HFFG N/A
- Revenue Growth
- GOSS N/A
- HFFG 1.53
- 52 Week Low
- GOSS $0.50
- HFFG $2.46
- 52 Week High
- GOSS $1.60
- HFFG $5.91
- Technical
- Relative Strength Index (RSI)
- GOSS 22.63
- HFFG 48.41
- Support Level
- GOSS $0.78
- HFFG $3.29
- Resistance Level
- GOSS $0.92
- HFFG $3.50
- Average True Range (ATR)
- GOSS 0.05
- HFFG 0.14
- MACD
- GOSS -0.01
- HFFG -0.01
- Stochastic Oscillator
- GOSS 0.00
- HFFG 42.86
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About HFFG HF Foods Group Inc.
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The Company's business consists of one operating segment; HF Group, which operates solely in the United States. The Company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.